APA (7th ed.) Citation

NB, M., P, D., & I, A. (2025). Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Subcutaneous Rusfertide, a Hepcidin Mimetic, in Healthy Subjects. Clinical pharmacology in drug development, 14(4), 311. https://doi.org/10.1002/cpdd.1514

Chicago Style (17th ed.) Citation

NB, Modi, Dinh P, and Ajari I. "Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Subcutaneous Rusfertide, a Hepcidin Mimetic, in Healthy Subjects." Clinical Pharmacology in Drug Development 14, no. 4 (2025): 311. https://doi.org/10.1002/cpdd.1514.

MLA (9th ed.) Citation

NB, Modi, et al. "Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Subcutaneous Rusfertide, a Hepcidin Mimetic, in Healthy Subjects." Clinical Pharmacology in Drug Development, vol. 14, no. 4, 2025, p. 311, https://doi.org/10.1002/cpdd.1514.